Partner, Venrock
Early-stage healthcare and life sciences investor
Bryan Roberts has been a Partner at Venrock since 1997, investing in early-stage healthcare and life sciences companies. His portfolio spans therapeutics, genomics, and health technology. He has backed more than thirteen companies that exceeded $1 billion in market cap, including Illumina, athenahealth, and Receptos. He was recognized by the NVCA with the Excellence in Healthcare Innovation Award in 2019.
Early-stage companies using novel biology, genomics, or technology platforms to transform healthcare delivery and therapeutics.
Typical check: $2M–$40M
Based in: Palo Alto, CA (North America)